| Durable SARS-CoV-2 B cell immunity after mild or severe disease CO Ogega, NE Skinner, PW Blair, HS Park, K Littlefield, A Ganesan, ... The Journal of clinical investigation 131 (7), 2021 | 115 | 2021 |
| Broadly neutralizing antibodies targeting new sites of vulnerability in hepatitis C virus E1E2 MD Colbert, AI Flyak, CO Ogega, VJ Kinchen, G Massaccesi, ... Journal of virology 93 (14), 10.1128/jvi. 02070-18, 2019 | 52 | 2019 |
| An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge AW Freyn, C Atyeo, PL Earl, JL Americo, GY Chuang, H Natarajan, ... Science translational medicine 15 (716), eadg3540, 2023 | 51 | 2023 |
| Optimizing glaucoma screening in high-risk population: design and 1-year findings of the screening to prevent (SToP) glaucoma study D Zhao, E Guallar, P Gajwani, B Swenor, J Crews, J Saaddine, L Mudie, ... American journal of ophthalmology 180, 18-28, 2017 | 46 | 2017 |
| A monkeypox mRNA-lipid nanoparticle vaccine targeting virus binding, entry, and transmission drives protection against lethal orthopoxviral challenge AW Freyn, C Atyeo, PL Earl, JL Americo, GY Chuang, H Natarajan, T Frey, ... BioRxiv, 2022.12. 17.520886, 2022 | 18 | 2022 |
| B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection CO Ogega, NE Skinner, AI Flyak, KE Clark, NL Board, PJ Bjorkman, ... PloS pathogens 18 (1), e1010179, 2022 | 8 | 2022 |
| Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in mice MA Wolf, JM O’Hara, GJ Bitzer, E Narayanan, DT Boehm, JR Bevere, ... npj Vaccines 9 (1), 103, 2024 | 7 | 2024 |
| Convergent evolution and targeting of diverse E2 epitopes by human broadly neutralizing antibodies are associated with HCV clearance CO Ogega, NE Skinner, MV Schoenle, XE Wilcox, N Frumento, DA Wright, ... Immunity 57 (4), 890-903. e6, 2024 | 5 | 2024 |
| Convergent antibody responses are associated with broad neutralization of hepatitis C virus NE Skinner, CO Ogega, N Frumento, KE Clark, H Paul, ... Frontiers in immunology 14, 1135841, 2023 | 5 | 2023 |
| Immunogenicity of a 30-valent M protein mRNA group A Streptococcus vaccine MB Finn, TA Penfound, S Salehi, CO Ogega, C Dold, O Plante, JB Dale Vaccine 42 (22), 126205, 2024 | 2 | 2024 |
| Corrigendum: Convergent antibody responses are associated with broad neutralization of hepatitis C virus NE Skinner, CO Ogega, N Frumento, KE Clark, H Paul, ... Frontiers in immunology 14, 1201033, 2023 | 1 | 2023 |
| Comparison of refractive error measurements in adults obtained by autorefraction and subjective refraction P Gajwani, LI Mudie, D Zhao, C Ogega, E Johnson, DS Friedman Investigative Ophthalmology & Visual Science 57 (12), 3978-3978, 2016 | 1 | 2016 |
| UTILIZATION OF SOLUBLE RECEPTOR BINDING PROTEINS TO CHARACTERIZE MOLECULAR AND PHENOTYPIC FEATURES OF MEMORY B CELL AND NEUTRALIZING ANTIBODY RESPONSES IN HEPATITIS C VIRUS OR … CO Ogega Johns Hopkins University, 2022 | | 2022 |
| Convergent antibody responses associated with broad neutralization of hepatitis C virus and clearance of infection NE Skinner, CO Ogega, N Frumento, KE Clark, S Yegnasubramanian, ... medRxiv, 2021.09. 11.21263416, 2021 | | 2021 |
| Multivalent mRNA-DTP vaccines are immunogenic and provide protection from MA Wolf, JM O’Hara, GJ Bitzer, E Narayanan, DT Boehm, JR Bevere, ... | | |
